Antibiotic Resistance Will Kill 300 Million People by 2050

My Healthwire.com — Feb 17, 2015                        Click here for full story

 

 

Expanded Study Confirms that Lyme disease May Be

Sexually Transmitted

PRWEB.com Newswire San Francisco, CA – Dec 19, 2014               Click here for full story

 

 

The Lingering Effects of Lyme disease

The StarPhoenix — Dec 3, 2014          Click here for full story

Australians Flock to Overseas Lyme disease Treatment

Yahoo! 7News – Nov 23, 2014             Click here for full story

 

 

WCIM 2014 – 32nd World Conference of Internal Medicine:

October 24 – 28, 2014 Seoul, Korea

“Internal Medicine & Beyond: Toward a Healthier World”

Professor Nasronudin – Chairman of ITD Airlangga University /Indonesia and a team of 22 researchers from ITD will be presenting their research paper:

Melaleuca Alternifolia Concentrate (98alive™) as a Casual Therapy of Dengue Infection –

At this prestigious international event in Seoul, Korea – October 24-28, 2014

About Melaleuca Alternifolia Concentrate (98alive™):

MAC/98alive™ has been developed by Professor Max Reynolds – Director of Griffith University’s Program for Australasia Botanical Medicine for Health (Ret) and Managing Director of 98 Alive Pty Ltd.

It is the result of more than a decade long development process, including extensive safety & efficacy testing and tens of millions of dollars in research by domestic and international laboratories.

Professor Reynolds is regularly invited to participate in scientific conferences and was scheduled as keynote speaker at the International Conference on Clinical Microbiology and Microbial Genomics – Valencia, Spain – September 24-26, 2014.


 

 

International Conference names Prominent Melaleuca Alternifolia researcher Professor Max Reynolds as Keynote speaker

Professor Max Reynolds has been named a Keynote speaker at the upcoming International Conference on Clinical Microbiology and Microbial Genomics to be held September 24-26, 2014 at Valencia, Spain – Hosted by OMICS Group International.

Professor

OMICS Group hosts over 350 leading edge peer reviewed open access journals and organize over 100 scientific international conferences annually.

The Groups conferences bring together renowned and eminent speakers, scientists and Nobel laureates from around the world – and their journals have over 3 million readers.

About Clinical Microbiology 2014

Clinical Microbiology – 2014 will focus on the most current research related to the laboratory diagnosis of human and animal infections and the role of the laboratory in both management of infectious diseases, the latest developments in clinical microbiology and immunology, providing the current state of knowledge in the field.

About Professor Max Reynolds, Developer of MAC/98alive™

Professor Reynolds has over a half a century’s experience in a broad range of research and global businesses. Professor Reynolds invented MAC/98alive™, a powerful anti-bacterial and anti-viral therapeutic product. His hands-on experience and determination to explore new, practical uses for biotechnology advances led to the development of all the applications for MAC/98alive™.

Professor Reynolds is the managing Director of 98 Alive Pty Ltd, an Australian based company dedicated to research on the therapeutic properties of Melaleuca Alternifolia against some of mankind’s most troublesome health problems. His wide ranging experiences both in research and practical manufacturing processes bring to the company 54 years of a range of exceptional skills including, but not limited to, multiple disciplinary utilization of chemistry, microbiology, organic chemistry and biochemical engineering knowledge.